Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyroxine in Acute Asthma Exacerbation
NCT02086799Unknown
- Sponsor
- Rambam Health Care Campus
- Start
- Jul 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of levothyroxine sodium in asthma (2 arms), sponsored by Rambam Health Care Campus. Primary endpoint: Time to normalization of Peak Expiratory Flow at 1 week. Status: unknown.
02
Drugs
levothyroxine sodium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02086799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02086799.